BRK-B vs FNWD
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
Finward Bancorp presents a complex profile with a stable Piotroski F-Score of 4/9 and a valuation that sits comfortably below its Graham Number ($41.32) and Book Value (P/B 0.87). While the company has shown an impressive recent trend of earnings beats and a massive YoY EPS recovery (+176.7%), this is contrasted by negative YoY revenue growth and a bearish technical trend. The significant gap between the Graham Number and the growth-based Intrinsic Value ($13.16) suggests the market is pricing in a recovery that hasn't fully materialized in top-line growth. Overall, it is a value play with improving earnings power but stagnant growth and poor capital efficiency.
Compare Another Pair
Related Comparisons
BRK-B vs FNWD: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Finward Bancorp (FNWD) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.